Daley-Yates, Peter T <br/><br/>
Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.  [electronic resource] 

 -  Journal of aerosol medicine and pulmonary drug delivery  Aug 2014 
 - 279-89 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1941-2703 
<br/><br/><label>Standard No.: </label>10.1089/jamp.2013.1040  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Adrenergic beta-2 Receptor Agonists--administration & dosage<br/>Adult<br/>Aerosols<br/>Aged<br/>Albuterol--administration & dosage<br/>Androstadienes--administration & dosage<br/>Area Under Curve<br/>Asthma--diagnosis<br/>Biological Availability<br/>Bronchodilator Agents--administration & dosage<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Drug Combinations<br/>Dry Powder Inhalers<br/>Equipment Design<br/>Female<br/>Fluticasone-Salmeterol Drug Combination<br/>Humans<br/>Lung--drug effects<br/>Male<br/>Middle Aged<br/>New South Wales<br/>New Zealand<br/>Particle Size<br/>Powders<br/>Pulmonary Disease, Chronic Obstructive--diagnosis<br/>Treatment Outcome<br/>Young Adult